Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2004-12-15
pubmed:abstractText
Previous immunohistochemistry studies have shown that the transcription factor, Egr-1, is increased in human atherosclerotic lesions but is absent from the normal adjacent aortic wall. The hypothesis was investigated that Egr-1 is also increased in calcified heart valve cusps because of the unique presence in these tissues of proteins known to be regulated by Egr-1, such as tenascin C (TN-C).
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0966-8519
pubmed:author
pubmed:issnType
Print
pubmed:volume
13
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
894-903
pubmed:dateRevised
2007-11-15
pubmed:meshHeading
pubmed-meshheading:15597579-Aged, pubmed-meshheading:15597579-Aged, 80 and over, pubmed-meshheading:15597579-Animals, pubmed-meshheading:15597579-Aortic Valve, pubmed-meshheading:15597579-Aortic Valve Stenosis, pubmed-meshheading:15597579-Calcinosis, pubmed-meshheading:15597579-Cardiomyopathies, pubmed-meshheading:15597579-Cell Proliferation, pubmed-meshheading:15597579-Cells, Cultured, pubmed-meshheading:15597579-Collagen, pubmed-meshheading:15597579-Early Growth Response Protein 1, pubmed-meshheading:15597579-Enzyme Inhibitors, pubmed-meshheading:15597579-Female, pubmed-meshheading:15597579-Humans, pubmed-meshheading:15597579-Male, pubmed-meshheading:15597579-Protein Kinase C, pubmed-meshheading:15597579-Sheep, pubmed-meshheading:15597579-Tenascin, pubmed-meshheading:15597579-Up-Regulation
pubmed:year
2004
pubmed:articleTitle
Transcription factor Egr-1 in calcific aortic valve disease.
pubmed:affiliation
Cardiology Research Laboratory, Children's Hospital of Philadelphia, Philadelphia, PA 19104-4318, USA.
pubmed:publicationType
Journal Article, Comparative Study